My office door is open most of the time. Visitors can be placed into two groups, business colleagues or shareholders. Business colleagues often come to my office to talk and seek advice on a wide range of business issues. Shareholders generally contact me by phone or email. All have questions that are important to them.

This blog gives me the opportunity to share my views on a broad range of issues that affect both groups. You will see that I look at things differently than you will find in the “official” world of the biotechnology and pharmaceutical industries and the business of being a public company. In the “unofficial” world, maybe I find myself in good company. I think it’s worthwhile to provide these views, not as a regular published column but rather as a source for my opinion on things I usually don’t discuss.

My door is open.